OnKure Therapeutics, Inc.
For the period ended Sep 30, 2026. Filed Nov 4, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 4, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
EXHIBIT INDEX
Incorporated by Reference
| ExhibitNumber · Description · Form · Filing Date · Number · FiledHerewith | ||||||
|---|---|---|---|---|---|---|
| 2.1 | Agreement and Plan of Merger, dated May 10, 2024, by and among Reneo Pharmaceuticals, Inc., Radiate Merger Sub I, Inc., Radiate Merger Sub II, LLC and OnKure, Inc. | 8-K | 5/13/2024 | 2.1 | ||
| 3.1 | Amended and Restated Certificate of Incorporation, as amended. | 8-K | 10/8/2024 | 3.2 | ||
| 3.2 | Amended and Restated Bylaws. | 8-K | 10/8/2024 | 3.3 | ||
| 4.1 | Form of Pre-Funded Warrant. | 8-K | 3/30/2026 | 4.1 | ||
| 10.1+ | OnKure, Inc. 2021 Stock Incentive Plan, as amended, and forms of agreement thereunder. | X | ||||
| 10.2+ | Form of Restricted Stock Unit Agreement (Performance Based) and Notice of Restricted Stock Unit Grant under OnKure Therapeutics, Inc. 2024 Equity Incentive Plan. | X | ||||
| 10.3+ | OnKure Therapeutics, Inc. Outside Director Compensation Policy, as amended. | X | ||||
| 31.1 | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 31.2 | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 32.1 | † | Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as | X | |||
| ExhibitNumber | Description | Form | Filing Date | Number | FiledHerewith |
| Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||||
| 101. INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document | X | |||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document | X | |||
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). | X | |||
- Indicates management contract or compensatory plan.
† This certification shall not be deemed filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that Section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.